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ABSTRACT:
The protein B52 is an essential component of the spliceosome in Drosophila M. and is
responsible for processing precursor-mRNA. B52 belongs to a family of proteins named SR
proteins which are critical in initiation and commitment of RNA splicing. Analogous to human
SRp55, B52 has been shown to be responsible for alternative and constitutive splicing during a
multitude of cellular and developmental events. RNA aptamers selected during an in vitro
selection and amplification process (SELEX) for B52 were found to have a co-variation in the
stem of these aptamers. Using biochemical and structural techniques, I will explore the RNAprotein interaction and discuss possible uses for future cancer treatments.

4

ACKNOWLEDGEMENTS:
I would like to thank Dr. Hua Shi and the Shi Laboratory for their guidance and resources
for the entirety of my research. Special thanks to Prabhat K. Mallik, Vomsee K. Chatakonda,
Daiying Xu, and Shengchun Wang. In collaboration with the Shi Laboratory I would like to
thank Dr. Carla Theimer and Kesha Smith for their patience and technical assistance.

5

TABLE OF CONTENTS:

Title Page……………………………………………………………….………………….. Page 1
Advisor/Committee Recommendation ………………………………………..…………Pages 2-3
Acknowledgements ……………………………………………………………………...…Page 4
Abstract ………………………………………………………………………….…………Page 5
Table of Contents ……………………………………………………….….………………Page 6
Introduction …………………………………………………………….………………Pages 7-16
Materials and Methods …………………………………………………..……………Pages 17-21
Results and Discussion ………………………………………………….……………Pages 22-28
Conclusion …………………………………………………...……………………………Page 29
References ……………………………………………………………………………Pages 30-32

6

INTRODUCTION:
One of the most prominent post-transcriptional processes is mRNA splicing. The process
has been proven to be a fundamental mechanism in possessing eukaryotic precursor transcripts
(pre-mRNA) by excising out intervening sequences called introns and ligating together
expressed sequences called exons. Appropriately named, the spliceosome is an ordered complex
of protein and RNA that is responsible for the splicing process. The ability of eukaryotic genes to
code for a vast number of proteins is rooted in the ability of the spliceosome to alternatively
splice. Alternatively splicing is a method of splicing in which different combinations of exons
are conjoined together allowing for a disproportionate number of proteins to be expressed
compared to the number of genes. These alternatively spliced proteins are called isoforms in
which many have similar function due to the similarity of their domains. The subsequent effect
of producing a variety of proteins allows for its use as tissue specific and developmentally
specific processes. Thus splicing must be strictly controlled in both time and space. This process
is controlled by the numerous proteins that make up the spliceosome. The spliceosome is made
up of small nuclear ribonucleoporteins (snRNPs) and non-snRNPs (Sharp 1994). The snRNPs
are generally responsible for the specific recognition of splice sites. A family of non-snRNP
proteins called SR proteins are serine-arginine rich and play a critical role in initiation and
commitment of pre-mRNA splicing (Manley 1996). [Figure 1]

Figure 1
Electron micrograph and interpretative drawing of DNA
template. The corresponding matured mRNA is shown in
green as the ligated exons. Introns are 4-10 times more
abundant then exons.

Fundamentals of Biochemistry 3rd Edition , Voet, pg. 967
http://www.cbs.dtu.dk/staff/dave/roanoke/euk-splice.gif
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SR proteins contain at least one conserved region called RNA-recognition motifs (RRMs)
at their N-terminus and a C-terminally located RS domain. The RS domain contains arginineserine dipeptide repeats and is responsible for protein interactions, notably the ability to recruit
snRNPs to the spliceosome, and both specific and general recognition of splice sites. SR proteins
bind to exonic splicing enhancers/silences (ESEs/ESSs) on the exon which are typically 5 to 10
nucleotides long. This binding is crucial in distinguishing from the longer intron sequences that
may contain consensus sequences. The RRMs contain two highly conserved regions (RNP1 and
RNP2) and have been proven to bind RNA with a high affinity. Drosophila SR proteins are
evolutionary conserved and are analogous to seven human SR proteins: SRp20, SRp30a
(SF2/ASF), SRp30b (SC35), SRp30c, SRp40, SRp55, and SRp75 (Zahler 1992). Most SR
proteins are essential splicing factors and function in early spliceosome assembly (Manley 1996).
SR proteins may seem redundant but it has been suggested that in alternative and constitutive
splicing that SR proteins play an important role in specifying splice sites and can act distinctively
in splicing (Zahler 1993).
B52 is a Drosophila SR protein analogous to human SRp55 and is lethal if deleted.
These two analogous proteins, B52/SRp55, are transcribed from a single gene of a highly
transcribed locus with chromosomal puffs (Fu 1995). Using increasing amounts of antibodies for
B52’s RRM reduces both spliced products and splicing intermediates proving that B52 functions
early in splicing activity. The induction of ftz transgene has shown that B52 depleted Drosophila
were still able to splice normally past the second-instar larvae. It is known that other SR proteins
are able to complement B52 deficient cells while no known mechanism is known at this time
(Hoffman 2000). Pirior studies have proven the overlapping as well as specific function of SR
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proteins, and specifically B52. A genetic screening for a second site enhancer of white apricot
has shown a dominate mutant for the B52, proving its function is specific (Peng & Mount 1995).
Recent research has placed a special emphasis on the topic of mapping the splicing
pathway in lieu of gene mapping. Out of the 13,472 genes in Drosophila M., 2,931were found to
have evidence of alternative splicing. These genes generate 8,315 differently spliced mRNA and
roughly that many isoforms. The development of a new Drosophila microarray platform has
allowed for the identification of hundreds of distinct and complementary splice events. This
newly developed microarray uses SL2 cells and a variable RNAi knockdown of splicing factors
and high-level of analysis to give powerful data in a global perspective of Drosophila pre-mRNA
splicing. Using these new methods it has been shown that B52/SRp55 and dASF/SF2 splicing
events are similarly affected by the RNAi knockdown of either splicing factor for the same 22
splicing events. While this does confuse the mapping of splicing pathways, the majority of B52
splicing events were proven to strongly and consistently be affected by solely B52/SRp55 in 105
specific targets. (Blanchette, 2005) Thus the characterization of B52’s RNA aptamers can be
used to explain how the functional overlap may be due to unique pre-mRNA sites, similar
binding specificities, or possible concomitant affects.
Alternative research in the field of hnRNP’s (heterogeneous nuclear ribonucleoprotein)
provides a reasonable source of cofounding information. The hnRNP family is a RNA-protein
complex of the SR proteins involved in splicing as well as accompanying pre-mRNA from the
gene to the nuclear pore. In particular, hrp45 is structurally similar to B52 but functions in an
opposite manor by ensuring pre-mRNA splicing is complete prior to mRNA removal from the
nucleus. Much like B52, hrp45 has been previously established as a splicing factor with
differential substrate specificity as well as overlapping functions. (Alzhanova-Ericsson, 1996) It
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has been found that hrp45 binds specifically to secretory protein gene transcripts and
accompanies these products to nuclear pores. (Signh, 2006) The hrp45 has been found released
in the nucleoplasm just prior to the unfolding and disassembly at the pore complex. (AlzhanovaEricsson, 1996) This field offers many leads and helps to advance the current studies of mapping
gene products, characterizing SR proteins, and identifying the mechanism in which splicing
occurs.
It has been established that the B52 protein is involved in eye development by alternative
splicing of the eyeless gene. The gene is evolutionarily conserved and is essential in Drosophila
eye development in Drosophila imaginal disc. B52 generates two isoforms of the eyeless protein
by alternatively splicing a 60 amino-acid exon. The longer isoform is known as the “Ey” protein
and can cause local eye over-growth, while the shorter “Ey(2a)” protein induces a small-eye
phenotype. It is believed that equal amounts of these proteins are required for normal eye
development in the eye imaginal disc. In the absence of B52 protein, there is two fold decrease
of Ey(2a) and two fold increase of Ey. Over-expression of B52 causes failure of the eye to form
which is characteristic of mutant Ey gene. The mechanism of this process is still unknown but in
vitro binding of B52 to exon 2 suggest its alterative splicing function (Fic 2007).
Not only does B52 play a fundamental role in Drosophila eye development but it has
recently been discovered to regulate Drosophila cell cycle. The EF2 gene is generally considered
a tumor suppressing gene and has two isoforms in Drosophila, de2F1 and de2F2 (Rasheva 2006).
These two proteins seem to work antagonistically with de2F1 as an activator, and de2F2 as a
repressor of S-phase entry and G1/S transcriptional program (Royzam 1997). When de2F1 is
mutated the fly shows obvious growth retardation and cellular failure to enter S-phase, while
de2F2 mutation has little effect. Interestingly and currently unexplainable is that when de2F1 is
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mutated, de2F2 can rescue de2F1 to continue cell proliferation. Elimination of B52 causes a
dramatic reduction of de2F2 proteins and activity of their target genes (likely de2F1). If B52 is
eliminated and de2F1 is mutated, def2F2 proteins lose the ability to rescue de2F1. Insertion of
intronless de2F2 in B52 deficient cells allows the rescue de2F1 and suggests that B52 acts as a
splicing enhancer for de2F2’s repressive properties (Rasheva 2006). The idea that B52 protein is
involved in the regulation of cell cycle increases its importance.
The implication to B52s possible use in cancer treatment has been recently exposed with
studies on human SRp55. Fibroblast growth factor receptor 1 (FGFR1) gene has been proven to
be alternatively spliced into two isoforms α-FGFR1 and β-FGFR1. These two isoforms differ in
their extracellular domains with different ligand affinity and subsequent signal transduction
pathways which are involved in embryo cell migration and cell proliferation. The α-FGFR1
isoform is found in normal human pancreatic and brain cells while malignancy of these cells has
shown excess β-FGFR1production with the exclusion of one exon. Using glioblastoma cells it
was was shown that two intron splicing silencers (ISSs) seem to contribute more to the inclusion
of this exon then the ESS that controls normal inclusion of this exon in α-FGFR1. It has been
observed that ESS mutations which reside next to ESE sequences can enhance SRp55 α-exon
inclusion, while the transfection of a specific RNAi can reduce SRp55 production and
subsequent inclusion of α-exon. This RNAi-mediated splicing of a specific exon is of great
significance to these studies on B52 because the RNAi is classified as a short hairpin RNA
interference (shRNAi) (Jin & Cote 2004). Besides the discovers of B52’s global function as a
splicing factor or its use during development, B52 has been discovered to function as a eclectic
protein within the nucleus.
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It has only recently been discovered in the past decade that splicing factors are involved
in transportation of the processed m-RNA to the nuclear pore. Recent data has also shown that
transcription speed can influence splicing of the transcript, and in a reciprocal manor, the
splicing of the pre-mRNA can modulate transcription. Of particular surprise and importance was
the discovery that B52 delivers DNA Topoisomerase I (Topo I) to RNA polymerase II-active
loci. The study used a highly specific drug called camptothecin, which traps the enzyme Topo I
once it has cleaved DNA. Topo I is responsible for relaxing the positive and negative
supercoiling of DNA during transcription as well as the phosphorlyation of B52. The use of
camptothecin results in inhibition of transcription, and prior inhibition had led to activation of
promotor-promixal transcription. It was proven the B52 and Topo I colocalize along chromosal
puffs in the nucleus by using Wee-P153 transgenic line that contains a GFP on the first intron of
the top1 gene, and standard anti-B52 serum. The perfect overlay of B52 (red) and Topo1 (green)
was then proven. Researchers were able to create a transgene that made use of the UAS-BBS
which expressed iaRNA (inhibitory aptamer RNA) with high affinity B52 Binding Sites. UASBBS under heat shock promoter was shown to recruit B52 specifically to the transgene which
was then shown to be accompanied by a GFP labeled Topo I. (Juge, 2010) The importance of
this discovery deeply broadens the scope of B52 manipulation. While there is little known about
the mechanism, the data was collected in vivo and offers the possibility of an intermediate
mechanism that could be used in future research.
B52 contains two RRMs, a consensus RRM and a degenerate RRM along with a long RS
domain that is typical of an SR protein. Using SELEX (Systematic Evolution of Ligand by
Exponential Enrichment) a specific consensus nucleotide sequence was found to bind B52.
SELEX is a process in which a large random pool of RNA is exposed to a target protein. The
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RNA is then eluted and amplified by PCR, this scheme is repeated while increasing the elution
conditions until only the highest affinity ligands are left. These bound RNA ligands are called
aptamers and while it is mostly unknown if they exist naturally they still exhibit high affinity to
specific targets. [Figure 2]

Figure 2

The aptamers for B52 were selected using a random 40 nucleotide regions flanked by
primers to over 100 nucleotides and put through nine rounds of selection, creating 3.4 × 1013
different sequences. Conveniently, the B52 Binding Sequences (BBS) were found to have a
characteristic hairpin loop predicted by free energy minimization. [Figure 3a] Both of the RRMs
of B52 are required for interaction with the BBS while the RS domain is not necessary. Only one
RRM has a consensus structure with a compact βαββαβ structure which may bind single stranded
RNA on surface of the four stranded β-sheet (Shi 1997). [Figure 3a & 3b]
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Figure 3a
Predicted secondary structures of B52
Binding Sequences with the consensus
motif in bold.
Shi, H. 1997

Figure 3b
Diagram of the B52 amino acid sequence
broken down into distinct domains with
their respective lengths.
Shi, H. 1997

In search of transcripts in which B52 splices specifically for use in aptamer research, a
representation of the Drosophila genome in 200-nt genomic sequences that bind B52 was in vitro
selected and amplified. This process of searching for homologous probes to screen the genomic
library used fewer PCR cycles and thermostable polymerase to reduce mutations. Of the 21
isolated clones, 13 are known genes according to Flybase, and all but one are implicated to
function in important cellular regulatory networks as opposed to transcription factors and/or
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signal transduction pathways. Interestingly, more than half of the 13 known genes contain
matches in their intronic regions which is unexpected. Using B52 null-mutants stalled in the
second instar-level of development, it was proven that B52 functions specifically in only 4 genes,
while the others can be compensated with of SR proteins. It was unsuccessfully shown that the
BBS aptamers selected for were faithfully present in these genes due to inability of suspected
BBS-like regions to bind B52. This demonstrates SELEXs ability to evolve the highest affinity
ligands without knowing if these sequences exist in vivo or will help to search known genomes.
The process of in vitro selection and amplification seems ideal theoretically but one of the major
draw backs is the evolution of undesired nonspecific ligands. The aptamers created for the
targeted B52 were thought to be functionally the same and only structurally different. One family
of aptamers called the Multi-G Motifs (MGMs) was thought to have been selected during
“Systematic Evolution of Ligand by Exponential Enrichment” (SELEX) as a result of
contamination because of their failure to bind the B52 protein (Shi 1997). [Figure 4] This family
of aptamers was later proven to have been selected for by the nitrocellulose filter used in the
SELEX partitioning step. The process of in vitro selection and amplification runs by the concepts
of evolution and thus allowed MGMs to outcompete some of the desired family of aptamers
called BBS. The BBS family of aptamers were the only RNA ligands proven to bind to splicing
factor B52 (Shi 2002). The ability to reduce unwanted selection of aptamers was made possible
by involving specific ribonuclease digestion which was proven effective against MGMs.

Figure 4
2.5% Agarose EMSA to test the affinity of
sequences competing for B52 in 20-uL
reactions.
Shi, H. 1997
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The subsequent aptamers being selected for gave a clearer outline of the BBS family.
Deletion and substitution mutations defined B52-binding site on these RNA as a hairpin loop
structure covering 20 nucleotides, which was confirmed by structure specific enzymatic probing.
When the bulge in BBS#8 was deleted (U bulge), the binding activity wasn’t compromised, and
an additional third BBS was found to bind B52. The most conserved sequence resides in the stem
but the loop is also critical for creating the protein-RNA interaction. A core 17-nt BBS of RNA
has been established. Using enzymatic probing of bound RNA allowed for a specific
identification of the protected nucleotides and confirmed the predicted BBS. These tests
confirmed the primary sequence and secondary structure of the RNA.
It has been estimated that 15% of human genetic diseases result from mutations in premRNA splicing defects and that altered levels of alternatively spliced proteins correlate to tumor
progression (Voet, Voet, & Pratt 2008). These facts have been proven for B52’s analogous SR
protein (SRp55) in FGFR1 alternative splicing. The significance of studying this RNA-protein
interaction has become enhanced with the use of shRNAi which has been proven to show
specific and efficient control of in vivo splicing. Studying the structural interaction between B52
and its aptamers may provide further insight into B52’s splicing mechanism in numerous cell
activities. The ability to create RNA aptamers with high affinity and specification towards B52
lends its possibility towards therapeutic use in cancer.
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MATERIALS AND METHODS:

In vitro Large-Scale RNA Transcription and Purification
The oligonucleotides were ordered from Integrated DNA Technologies, Inc. The DNA
template has only 2 cytosine base pairs added to increase stability, and provide a structurally
convenient hairpin loop. The concentration of the DNA was measured using a UV/VIS
spectrometer. The actual concentration was 100nM less than requested which is to be expected.
A T7 promoter strand “T7 Top” was annealed to the DNA in an equimolar ratio by combing
50µM of each and adding water to reach the final volume. Reaction was allowed to anneal at
95°C for 3 minutes.
Prior to running large scale, a small scale optimization transcription was run, and the
subsequent parameters were used in large scale. Large scale transcription was conducted by
reacting each 100mM NTPs, 100mM DTT, 1X Transcription Buffer (400mM Tris-HCl pH 8.0,
10mM spermidine, .1% (v/v) Triton X-100), 1M MgCl2, 50µM Annealed DNA stock, T7 RNA
Polymerase, and water for six hours in a 37°C incubator. After six hours the reaction mix was
spun for 5 minutes at 4,000 rpm and the supernatant was collected. Added 1/10 volume of 0.5M
EDTA pH8.0, and 2.5-3X volume of cold 100% ethanol to supernatant. The first centrifuge is to
remove the magnesium pyrophosphate. The EDTA will chelate the remaining Mg and the 100%
ethanol to precipitate the RNA in -20°C freezer overnight.
Centrifuge the RNA mixture at 12,000 rpm for 45 minutes. Dry the pellet out under the
hood for 2 hours, then resuspend pellet in denaturing nucleic acid polyacrylamide gel loading
buffer (80% (v/v) formamide, 10mM EDTA pH8.0, 0.25% (w/v) bromophenol blue, and 0.25%
(w/v) xylene cyanol). Each RNA was loaded onto its own denaturing polyacrylamide gel (20%
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Acrylamide:10% APS:TEMED in at 1:100:1000 ratio). Use 1X Tris-Borate-EDTA buffer and set
power supply to 25 Watts/gel for 20 hours. The gel took 1 hour to cool, and extensive cleaning of
the wells was used as a precaution against contamination. Place the gel on TLC plates which
allows visualization of the RNA under short wavelength UV light. The UV shadow was cut out
and placed in an electroelution setup called Elutrap, using BT1 and BT2 membranes and 1X
Tris-Borate-EDTA buffer. Fractions were collected every 3 hours at 150 volts.
For purification an anion exchange column with DEAE-resin was used. The column resin
is positively charged and binds to the negatively charged RNA, which can then be eluted off with
high salt buffers which have a higher ionic strength. The purified RNA was then stored in 2.5-3X
100% ethanol to precipitate the RNA. The final yield of transcripts was 260nmole, 114nmole,
and 281nmole of purified AA, AAU, and GC respectively

B52 Protein expression and purification
Escherichia Coli BL21 cells were used to transform with a plasmid encoding the genes
for the expression of a histidine tagged B52-RRM12. Over-expression of protein in bacterial
cells is a simple and efficient way to produce high concentration protein. The DNA plasmid was
added to cells and heat shocked for 30 seconds at exactly 42°C. After cooling for 2 minutes,
250ul of SOC solution was added and cells were incubated for 1 hour at 37°C shaking at 250
rpm. The cells were spread on Agar plates (Ampicillin and Chloramphenicol) and placed in 37°C
incubation overnight.
The culture was scraped into an LB Broth (containing Ampicillin and Chloramphenicol)
and incubated at 37°C for 16 hours. The overnight culture was then used to inoculate LB Broth
at 37°C shaking at 225 rpm while the OD (optical density) was measured every hour. Once the
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OD reached 0.8 the bacteria were induced with IPTG to 1mM, incubated at 37°C for four hours,
and then spun down to pellets which were stored at -20°C. The pellets were resuspended in 5mL
of denature lysis / binding buffer ( 100mM NaH2PO4, 10mM Tris base, 8M urea pH 8.0) for
every gram of pellet. The pellets were sonicated (Amplitude 45%, Pulse on .3 sec, Pulse off 1
sec) to lyse the cell and allow the protein into solution. The cellular debris were collected by
centrifuge at 10,000 rpm for 25 minutes.
The protein was then run in a Nickel column in 4°C. Refolding buffers with a decreasing
amount of urea were used to refold the protein and then the protein was eluted out with 500mM
imidazole which outcompetes Histidine for Nickel binding. A Sodium-Dodecyl-Sulfate poly
acrylamide gel electrophoresis (SDS-PAGE) was run in order to analyze the purity of the
fractions and appropriate size of approximately 26 kDa. The protein was dialysized for two hours
into a protein buffer (20mM Tris(hydroxymethyl)aminomethane, 200mM NaCl, 2mM DTT,
15% Glycerol, and 1mM PMSF) using spectrapore membrane tubing with cutoff MW of 12,00014,000. The fractions were then pooled together and concentrated down using Amicon Ultra
Centrifugal Filter Device. The concentration of the protein was determined using the SDS-PAGE
with known amounts of BSA to visually approximate band strength.

RNA-Protein Binding Reaction
To test the binding efficiency 32P-labeled RNA were probed against different
concentrations of B52 protein. The template oligonucleotides were ordered from Integrated DNA
Technology with a T7 promoter sequences incorporated and an additional three cytosine dNTPs
at the first three transcription positions to increase stability of the molecule and thus increase
transcription efficiency. Each template was made into 1mM stock solutions with DEPC treated
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H20 and stored at -20°C. The DNA templates were annealed to 1mM of T7 top at 95°C for 3
minutes to create a 50uM annealed stock. The 50uM annealed stock was then primer extended on
a thermal cycler (denatured at 95°C for 5 minutes, annealed at 62°C for 10 minutes, and
extended at 72°C for 30 minutes) with elevated temperatures due to the high Tm of the
oligonucleotides. The RNA was uniformly labeled with [α-32P] ATP by using T7 MAXIScript in
vitro transcription kit according to the manufacturer’s instructions. To test the presence and
purity of the 32P-RNA a 20% denaturing gel (20% acrylamide (30:1 acrylamide:bisacrylamide),
1X Tris-Borate-EDTA, 7M urea, 10% APS, TEMED) was run at 200 volts for 35 minutes. The
RNA was reconstituted in 1x Binding Buffer (50mM Tris-Cl, pH7.6, 200mM KoAc, 5mM
MgCl2, 2.5mM DTT) containing approximately 25fmol of each probe. The binding reaction
typically used 0 to 20 pmole of truncated B52 protein to allow stoichiometric visualization of the
binding. Besides the protein-RNA complex and binding buffer the reaction contained BSA
(5mg/mL), and Yeast RNA (5mg/mL) which were incubated at 37°C for 45 minutes.

Agarose EMSA and Filter Binding
The standard 20µL binding reactions were loaded with 20% glycerol onto a 2.5%
Agarose gel with 0.25% Tris-Borate-EDTA buffer at 100 volts in 4°C. The gel was dried on
Whatman paper and DEAE (Whatman DE81) at 50°C for 2 hours. The gel was then exposed to a
phosphoimaging screen for 5 to 10 minutes and read by a Storm 860 scanner.
Nitrocellulose binding and immobilization paper was obtained from Schleicher and
Schuell with a 0.45 µm pore size. The nitrocellulose filter paper was placed in the filter binding
apparatus with slit-blot top and washed with 200 µL of 1x binding buffer prior to loading
reactions. Immediately after loading the 20 µL binding reactions onto the membrane, the wells
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were washed with an additional 1 mL of binding buffer to reduce nonspecific background
retention. The nitrocellulose paper was then exposed to a phosphoimaging screen for 5 to 10
minutes and read by a Storm 860 scanner.

UV Melting Analysis
UV melting was obtained using a Cary 300 Scan UV-Visible Spectrophotometer of five
different sample. The RNA aptamers from the large scale transcription were each tested with five
samples of vary amount of NaCl concentration from 50mM to 1 M (10mM 3-(Nmorpholino)propanesulfonic acid pH 7, and 5µM RNA). This variation in ion concentration
allows determination of the range in which the transitions are visible under. The samples were
annealed at 65°C for 10 min and then cooled to room temperature before being placed in
spectrophotometer. The use of blank samples and a temperature control were used to provide
baseline readings.
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RESULTS AND DISCUSSION:

Co-Variation
The evaluation of BBS aptamers confirmed the 17-mer consensus region that makes up a
hairpin loop but also revealed variation within this conservative region. The positions of 2, 9, and
16 seem to vary among the BBS family while the other positions are highly conserved (Shi
2002). There are three different RNA’s that bind with equal affinity to BBS: a 22-mer B52GC, a
23-mer B52UGC, and a 24-mer B52AA. The particular positions of #2 and #16 are of special
interest because they reside in the stable stem structure forming a co-variation. [Figure 5] One of
the base pair combinations is theoretically a non-Watson-Crick base pair A-A, while the other is
a typical Watson-Crick G-C. The A-A variant forms an internal loop with unpaired bases (A-C
and G-A) which may due to some structural change that compensates for this entropically
unfavored secondary structure, making the BBS variations isosteric. The UG-C variant was the
other aptamer synthesized with a U bulge and further investigation showed that the U bulge can
be removed to still produce active binding with B52, called the GC variant. These two variants
(UGC and AA) were shown to evolve in equal frequency and can compete equally well for B52
binding (Kim et al, NAR 31:1955). With the BBS family well defined we were able to test these
minimal aptamer stem-loops towards B52 binding. These three co-variants all compete equally
well for B52 binding. The reason for this is unknown and we hope to uncover the answer through
studying the structure of these aptamers.
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Figure 5

Agarose EMSA
This past academic year I have successfully expressed and purified the His-Tagged B52RRM12 construct and prepared radiolabeled RNA probes, including the original aptamer and
three short derivatives. [Figures 6,7, & 8] However, thus far there has been very little success
with visualizing the binding reaction. [Figure 8] 32P –Labeled BBS#8 and over expression of the
B52-RRM12 protein have been shown to successfully replicate the positive control in filter
binding. Due to trouble transcribing the labeled RNA, additional G base pairs was added to the
stem of each aptamer co-variant. The shift will hopefully show the ability of the co-variants to
bind equally efficient compared to each other as well as compared to the BBS#8. The use of
filter binding will provide an outline for binding efficiency which will then be quantified on an
Agarose EMSA. This will be measured in the dissociation constant (Kd) which measures the
complexs ability to fall apart into complement molecules. Using an excess amount of protein
compared to RNA allows for a calculation which negates the difference between free and total
protein. Since the RNA is radiolabelled, it can provide visualization of the RNA-Protein complex
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which can then be subtracted from total RNA to calculate free RNA. With at least a 100 fold
excess of protein, the Kd can calculated with equation 1.

Equation 1

Kd =

[Protein]total[RNA]free
[Protein-RNA]

Figure 6

=

[Protein]total

[RNA]free
[Protein-RNA]

Figure 7

SDS-PAGE of increasing concentrations of BSA
(1µg, 5µg, 10µg, and 20µg) against purified B52
protein to approximate its concentration.

Figure 8

24

It is extremely unlikely that the binding doesn’t occur considering that the co-variants
contain the active stem loop region which is further stabilized by G-C pairs, and the truncated
B52 protein has already been shown to bind the original aptamer with high affinity. The failure
of the shift assay is possibly due to dissociation of the B52 protein-RNA complex on the gel. To
ensure that the protein remains active, further precautions can be made to keep the temperature
low during purification and EMSA. To check for RNA contamination and correct transcription
the RNA preparation can be run on a larger 20% polyacrylamide-7M urea gel. The gel will give
a better approximation of the RNA concentration as well as check the size of the transcribed
RNA. [Figure 9a &9b]
Figure 9b
Figure 9a

\

Structural Analysis
Heating and Cooling of RNA under quasi-stationary conditions the RNA can be unfolded
from their native disordered state into an ordered folding when cooled. The temperature at the
midpoint of this transition is termed Tm. The hypochromicity of stacked bases provides an
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extremely sensitive to UV absorbance at 260nm and 280nm. Uses two wavelengths allows for
the minimal number of transitions to be viewed. If the derivative of absorbance relative to
temperature is plotted (dA/dT) is plotted, corresponding peaks represent partial transitions in the
RNA folding. Lower peaks typical represent tertiary unfolding (pseudoknots, water bridges, and
canonical base pairs) while higher temperature peaks represent more stable bases (bulges, loops,
hairpins, and junctions). The ΔS and ΔG can be tabulated and using the nearest neighbor model
for Watson-Crick and non-Watson-Crick basepairs. The ΔH and ΔG can be predicted and fitted
to create the theoretical curve to coincide the observed curve. At this point in time the data from
UV melting is being tabulated and fit for the three minimal stem-loop structures.
The use of NMR spectroscopy will allow for observation of resonating protons in a
magnetic field. The presence of imino protons (N-H) on the purine’s, Guanine and Uracil,
produce characteristic chemical shifts that are useful in NMR structural studies. These shifts can
be used to indicate Watson-Crick base pairs through interaction with other imino protons. Due to
the fact that Watson-Crick base pairs of G-C and A-U each have an imino proton, there will
typically be a peak for each base pairs. Once the 2D NMR data has been collected it can be
analyzed for non Watson-Crick base pairs, and to prove that the aptamer sequences are
representative of the predicted secondary structure. To conduct the spectroscopy takes a
considerable amount of RNA, at least 100nmoles, after which 3D NMR spectroscopy can be
conducted to determine tertiary structure to determine the exact position of each nucleotide. At
this point in time the RNA is being purified and concentrated to be run on NMR and will provide
further insight into the structure of these three aptamers.
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Purposed Structure
There have been recent structurally studies on similar motifs which also contain a
conserved sequence and internal loop structures. A very similar aptamer that was also
synthesized used SELEX is a nucleolin-recognition element (NRE) which is recognized by the
two RRMs of nucleolin. Nucleolin is a nucleolar phosphoprotein involved in the maturation of
ribosomes. The NRE makes up a core 18-nt flexible stem-loop structure with its stem containing
a loop E motif and its loop able to exchange between differing conformations. This equilibrium
between the stem and loop is unique among RNA-protein complexes and increases the
possibility of discovering a novel binding interaction between BBS-B52. The use of NMR
allowed a purposed RNA to adopt a loop E motif, with an S-turn backbone, as well as the 2
RRMs surrounding the NRE aptamer. (Bouvet 2001) [Figure 10]

Figure 10

Similar studies have been conducted with homologs to SR proteins in yeast, such as
NpI3, a family of RNA-binding proteins that protect proper transcription. Recent research has
discovered the structure of NpI3’s interaction with RNA is able to balance transcription and
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termination through the use of NpI3’s two RRMs. It was concluded that NpI3 bound in a similar
fashion that NRE does and was supported with NMR data showing that the two RRM domains
do not interact with each other in RNA-free form, while the linker region becomes ordered in
concomitant with the rest of the complex. A major and significant difference with NpI3 is that it
appears to have a 5:1 stoichiometry difference between RRM2 and RRM1 affinity. While these
sequences recognize G+U rich oligionucleotides the NMR data proves RRM-2 to form a much
stronger interaction. (Deka, 2007) While NpI3 protein doesn’t have sequence specific binding of
its RRMs like B52 does, it opens a possibility for the B52-RNA interaction. It is possible that
one of B52’s RRMs recognizes the specific RNA consensus sequence with a much higher
affinity then would be need to recruit other proteins to the splice site.
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CONCLUSION:
The research conducted in the field of splicing factors has been growing exponentially
over the past decade. Of which, SR protein B52 and its homolog SRp55, seem to be showing the
most promise in their multitude of cellular events. B52 has been proven to be critical in:
alternative and constitutive splicing, overlapping and specific splicing, eye development, cell
cycle check points, splicing in cancer cells, packaging of mRNA, and delivery of Topo I. The
protein B52 sits in the middle of a tangled mechanism which holds the key to future cancer
therapy and understanding gene products. While this thesis provides a good ground to which B52
can be further explored, the full characterization of B52 will soon be needed.
With great expertise in this area I would suggest future research towards applied gene
therapy using RNA aptamers. It has been stated that B52 associates with chromosomal puffs and
is a known essential component of transcription. Since B52 is more prominent in developing
cells and is concurrently being mapping in a specific and systematic way in relation to specific
genes, a climatic point is being reached. I would suggest the development of a multi-valent
aptamer that is capable of recognizing B52 activation in stem-cell niches that are undergoing
cancerous chromosomal puffs. This development is only years away and the methods that make
this feasible have only recently been implemented. The creation of a tetravalent aptabody that
can recognize two B52 proteins is a great starting point and offers promise to this study. (Xu,
2009) With a myriad of advantages over protein/antibody use in therapeutic cancer treatment,
RNA aptamers selected to control splicing proteins, and in particular B52, should begin to
become a more plausible intervention over the decades to come.
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